TUNZ Pharma Co., Ltd.
TUNZ Pharma's Joint Research Project Selected in the AMED Call for Proposals on Seeds (Second Round) for the FY2020 Strategic Promotion Program for Translational Research
Exclusive Agreement with a South Korean Biomaterials Company on Joint Development and Marketing Rights of BMP-2 Formulation in Japan
The Nikkei hails TUNZ Pharma as a new business model for regenerative medicine research
Corporate website launched